FDA’s Preliminary Review of GLP-1 Meds Finds No Tie to Suicidal Thoughts, Actions Healthcare Resources By On Jan 11, 2024 0 Share The FDA has found no clear relationship between GLP-1 drugs, such as Ozempic and Mounjaro, and reports of suicidal thoughts or actions. But the agency added that it can’t definitively rule out the risk, and its review is ongoing. 0 Share